CHIP Faculty Member Awarded Grant to Study Provider Compliance to the 2017 Hypertension Treatment Guidelines

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institute of Health (NIH) recently awarded CHIP Faculty Member Yacob Tedla, PhD, with a grant to study provider compliance to the 2017 Hypertension Treatment Guideline, examining the association between guideline compliance and the trajectory of blood pressure of patients.

The 2017 hypertension treatment guideline changed the definition of uncontrolled blood pressure (BP) to ≥130/80 mm Hg (from ≥140/90) and BP threshold for the initiation of antihypertensive medication for patients at higher risk of cardiovascular events. This updated guideline challenges physicians to change their traditional hypertension management and could worsen the already low rate of compliance (range 25-65%) to hypertension treatment guidelines.

The study will evaluate multiple aspects of hypertension care, such as lifestyle, medications, co-morbid conditions, follow-up and laboratory assessments, and patients’ race. Ultimately, the study will aim to determine:

  • The level and determinants of compliance to the 2017 hypertension treatment guideline;
  • The association between guideline compliance and patient blood pressure pattern.

Co-Investigators and mentors include CHIP Director Abel Kho, MD, Northwestern Medicine Harry W. Dingman Professor of Cardiology Philip Greenland, MD, and Northwestern Medicine Vice Chair of the Department of Preventive Medicine Mercedes Carnethon, PhD.

Learn more about the project on the project page.

« Back To News

Join Us

CHIP collaborators are part of the public, private and nonprofit sectors and have an interest in working toward a world where health outcomes are improved because data is used effectively.

Get in Touch

Join Our Mailing List


Don't Forget To Connect